<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03361813</url>
  </required_header>
  <id_info>
    <org_study_id>201617019.2P</org_study_id>
    <nct_id>NCT03361813</nct_id>
  </id_info>
  <brief_title>Pre-emptive Trans-cutaneous Versus Trans-oral Ultrasound Guided Peritonsillar Infiltration With Bupivacaine During Tonsillectomy</brief_title>
  <official_title>Comparative Study Between Pre-emptive Trans-cutaneous Versus Trans-oral Ultrasound Guided Peritonsillar Space Infiltration With Bupivacaine During Elective Tonsillectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ultrasound as a technique is safe, readily available, quick and portable allowing more
      accuracy of different regional blocks and local infiltration. It allows imaging of the mouth,
      oropharynx, infrahyoid structures, larynx, vocal cords, and trachea. Recently, ultrasound has
      been shown to improve accuracy in ultrasound guided block with local anesthetic infiltration.
      The objective of our study is to compare the effect of pre-emptive trans-oral ultrasound
      guided peritonsillar infiltration versus trans-cutaneous ultrasound (US) guided peritonsillar
      infiltration with bupivacaine for post-tonsillectomy analgesia, on surgical field, and
      surgeon satisfaction(intra-operative reactionary bleeding).

      Materials and Methods: the patients will be admitted for tonsillectomy at ENT department of
      the Al- Azhar university hospitals. The patients' ages between 3 to 15 years. Patients will
      be divided into Cutaneous group: patients will be submitted to Trans-cutaneous ultrasound
      guided peritonsillar infiltration with bupivacaine, and Oral group: patients will be
      submitted to Trans-oral ultrasound guided peritonsillar infiltration with bupivacaine.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 10, 2017</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical field (intra-operative reactionary bleeding and/or muscle tear)</measure>
    <time_frame>time of surgery</time_frame>
    <description>Iintra-operative reactionary bleeding and/or muscle tear assessment by number of soaked gauze per 20 min (per tonsil) (3 soaked gauze per 20 min (per tonsil) = no reactionary bleeding (0 point), 6 soaked gauze per 20 min (per tonsil) = mild bleeding (1 point) and 10 soaked gauze or more per 20 min (per tonsil) = moderate to severe bleeding (2 points).
Dissection time assessment (dissection time 10 min or less per tonsil = no bleeding (0 point), dissection time 20 min per tonsil = mild bleeding (1 point) and dissection time 30 min or more per tonsil = moderate to severe bleeding (2 points).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Surgeon satisfaction</measure>
    <time_frame>time of surgery</time_frame>
    <description>Direct surgeon questionnaire assessment about bleeding and surgical field (full satisfaction= no bleeding (0 point), fair satisfaction= mild bleeding (1point), and poor satisfaction= moderate to severe bleeding (2 points)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Postoperative Pain Management</condition>
  <arm_group>
    <arm_group_label>trans-cutaneous ultrasound guided peritonsillar infiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>trans-oral ultrasound guided peritonsillar infiltration</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>trans-cutaneous ultrasound guided peritonsillar infiltration</intervention_name>
    <description>Preoperative peritonsillar infiltration of bupivacine in tonsillectomy surgery by using the ultrasound through a transcutaneous route</description>
    <arm_group_label>trans-oral ultrasound guided peritonsillar infiltration</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>trans-oral ultrasound guided peritonsillar infiltration</intervention_name>
    <description>Preoperative peritonsillar infiltration of bupivacine in tonsillectomy surgery by using the ultrasound through a trans-oral route</description>
    <arm_group_label>trans-cutaneous ultrasound guided peritonsillar infiltration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA (American Society of Anesthesiologists) physical status I-II with no airway
             complications or systemic diseases or known psychological diseases. Reason for their
             surgery was recurrent or chronic tonsillitis.

        Exclusion Criteria:

          -  Infection at the site of injection, peritonsillar abscess or cellulites.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Warda D K Ali, MD</last_name>
    <phone>01224668648</phone>
    <phone_ext>002</phone_ext>
    <email>warda2001@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Al-Azhar University Hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Warda DK Ali, MD</last_name>
      <phone>0122668648</phone>
      <phone_ext>002</phone_ext>
      <email>warda2001@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2017</study_first_submitted>
  <study_first_submitted_qc>December 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 5, 2017</study_first_posted>
  <last_update_submitted>December 9, 2017</last_update_submitted>
  <last_update_submitted_qc>December 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed H Othman</investigator_full_name>
    <investigator_title>Assisstant professor of Anesthesia ICU and pain Relief</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

